BiotechTube
Home/Pipeline/HGF Gene Therapy

HGF Gene Therapy

Cardiovascular Disease

Phase 2Active

Key Facts

Indication
Cardiovascular Disease
Phase
Phase 2
Status
Active
Company
AnGes

About AnGes

Japanese biotech developing gene therapies and biologics for cardiovascular and critical care conditions.

View full company profile

Therapeutic Areas

CardiovascularCritical CareRare Diseases

Other Cardiovascular Disease Drugs

DrugCompanyPhase
Manocept DiagnosticNavidea BiopharmaceuticalsResearch
Undisclosed Therapeutic Program(s)HeartcoR SolutionsPre-clinical
Ramatroban (KAR101)KARE BiosciencesPreclinical
Undisclosed Cardiovascular Device ProgramTransluminal TechnologiesPre-clinical
iPSC-CM Cell TherapyKhloris BiosciencesResearch
Clinical Trial IntegrationAktiiaVarious
Cardiovascular Disease StudyArizona Research CenterNot Specified
Cardiovascular Clinical TrialsPanThera BioNot Specified
UndisclosedZecardio TherapeuticsDiscovery/Pre-clinical
HDL/LDL RegulationAlpha-1 BiologicsPre-clinical
Cardiovascular ProgramHelixomerResearch
Undisclosed Cardiovascular PrograminQB8 Medical TechnologiesPre-clinical